Life Science Tools amp Reagents

Life Science Tools & Reagents Market Outlook

The global Life Science Tools & Reagents Market is projected to reach approximately USD 68 billion by 2035, growing at a CAGR of around 7.5% during the forecast period of 2025-2035. The growth of this market can be attributed to several key factors, including the increasing demand for advanced diagnostic tools, the rising prevalence of chronic diseases, and the ongoing advancements in genomics and proteomics technologies. Furthermore, the growing emphasis on personalized medicine and the need for effective drug development strategies are fueling market expansion. As more pharmaceutical and biotechnology companies invest in research and development, the overall demand for life science tools and reagents continues to surge, paving the way for innovative solutions in the healthcare sector. Additionally, the increased funding for life sciences research and the globalization of research initiatives are expected to enhance market growth significantly.

Growth Factor of the Market

Several factors contribute to the growth of the Life Science Tools & Reagents Market. Firstly, the expanding applications of life science tools in various sectors including academic research, clinical diagnostics, and pharmaceutical development are driving demand. The advancements in technology, particularly in genomics and proteomics, facilitate the development of novel reagents and tools that improve the efficiency and accuracy of research. Additionally, the rising incidences of infectious and chronic diseases around the world highlight the necessity for innovative diagnostic solutions, thus propelling the market. Moreover, an increase in the number of research collaborations between academic institutions and pharmaceutical companies fosters an environment ripe for market expansion. Lastly, government initiatives and increased funding in healthcare and life sciences are instrumental in driving advancements and adoption of innovative tools and reagents.

Key Highlights of the Market

• Projected market size of approximately USD 68 billion by 2035.
• Anticipated CAGR of 7.5% from 2025 to 2035.
• Significant adoption of genomics and proteomics technologies.
• Growing prevalence of chronic diseases influencing diagnostic needs.
• Increased investment in drug discovery and personalized medicine.

By Product Type

Cell Biology Reagents:

Cell Biology Reagents are crucial components in life science research, providing researchers with the necessary tools to manipulate and analyze cell structures and functions. The demand for these reagents is significantly driven by advancements in cell-based assays and high-throughput screening methods that are increasingly adopted in drug discovery and development. Moreover, the growing interest in cell therapy and regenerative medicine further propels the market for cell biology reagents. As researchers continue to uncover new cellular mechanisms and interactions, the need for innovative reagents to support these studies will contribute to sustained market growth in the coming years.

Genomics Tools:

The Genomics Tools segment has witnessed remarkable growth due to the rapid advancements in sequencing technologies and the decreasing costs of genomic analysis. These tools facilitate various applications in genetic research, including whole-genome sequencing and targeted gene analysis, which are essential for understanding genetic disorders. The demand for genomics tools is further driven by the increasing focus on personalized medicine, where tailored therapies based on genetic profiles are becoming more prevalent. As genomic research continues to evolve and expand, the market for genomics tools is expected to experience robust growth, supported by ongoing technological innovations and research investments.

Proteomics Tools:

Proteomics Tools play an essential role in understanding protein functions and interactions, which are crucial for drug development and disease diagnostics. The surge in proteomics research, fueled by the need for biomarker discovery and validation, has significantly bolstered the demand for these tools. Advanced technologies such as mass spectrometry and protein microarrays are increasingly being used in proteomics studies, providing deeper insights into cellular mechanisms. As the pharmaceutical industry continues to invest in proteomic research for drug discovery and development, the market for proteomics tools is anticipated to grow substantially over the forecast period.

Antibodies:

Antibodies are integral reagents used across various applications in life sciences, including diagnostics, therapeutics, and research. The increasing prevalence of chronic diseases and the demand for targeted therapies have heightened the need for high-quality antibodies in research and clinical diagnostics. Additionally, the rise of monoclonal antibodies as therapeutic agents has further stimulated the market. Innovations in antibody engineering and production technologies are also expected to enhance the availability and specificity of antibodies, thus driving their demand in various applications. As research continues to explore new avenues in immunotherapy, the antibodies segment will likely see significant growth.

Flow Cytometry Instruments:

Flow Cytometry Instruments are pivotal in cell analysis and sorting processes, allowing researchers to gather quantitative information on single cells suspended in a fluid stream. This technology is widely used in various applications, including immunology, cancer research, and stem cell studies. The growth of this segment is propelled by advancements in flow cytometry techniques, which enable more precise and rapid analysis of cell populations. Furthermore, the increasing focus on personalized medicine and the growing need for cell-based therapies are expected to drive the demand for flow cytometry instruments, reinforcing their importance in life sciences research and clinical diagnostics.

By Application

Drug Discovery:

Drug Discovery remains one of the most significant applications of life science tools and reagents, as pharmaceutical companies continually seek innovative solutions to develop new therapeutics. The process of drug discovery encompasses a range of activities, including target identification, lead discovery, and preclinical testing, all of which require advanced tools and reagents for success. The increasing incorporation of technologies such as high-throughput screening and in silico modeling has streamlined the drug discovery process, enabling faster and more efficient development timelines. As the global demand for new and effective drugs continues to rise, the drug discovery application segment will likely witness sustained growth.

Research:

The Research application segment is critical for advancing scientific knowledge and understanding in various fields, including biology, genetics, and biochemistry. Life science tools and reagents play an instrumental role in facilitating research activities, allowing scientists to conduct experiments with precision and reproducibility. The rising number of research initiatives and collaborations across academic and industrial sectors underscores the importance of having access to high-quality tools and reagents. Furthermore, the increasing focus on interdisciplinary research and the development of innovative methodologies are expected to further enhance the demand for research-related life science tools and reagents.

Clinical Diagnostics:

Clinical Diagnostics is a vital application of life science tools and reagents, as accurate and timely diagnostic testing is crucial for patient management and treatment decisions. The increasing prevalence of chronic diseases and infectious conditions has amplified the need for advanced diagnostic solutions. The introduction of novel diagnostic techniques, including molecular diagnostics and point-of-care testing, has transformed the landscape of clinical diagnostics, necessitating the availability of high-quality reagents. As healthcare systems worldwide continue to prioritize early detection and personalized treatment, the clinical diagnostics application segment is projected to expand significantly.

Genomic Analysis:

Genomic Analysis is becoming increasingly important in understanding the genetic basis of diseases and developing targeted therapies. The growing accessibility of next-generation sequencing technologies has revolutionized genomic research, allowing for comprehensive genomic profiling and analysis. The demand for life science tools and reagents that support genomic analysis is surging, driven by the need for accurate and efficient methods in genetic research and diagnostics. As researchers continue to explore the complexities of the genome, the genomic analysis application segment will likely experience strong growth, supported by ongoing technological advancements.

Proteomic Analysis:

Proteomic Analysis is pivotal in elucidating protein functions and interactions, which are essential for understanding cellular processes and developing novel therapeutics. The increasing recognition of the role of proteomics in drug discovery and disease diagnostics has significantly bolstered the demand for proteomic analysis tools and reagents. Advanced techniques such as mass spectrometry and protein microarrays are being utilized to uncover biomarker signatures and therapeutic targets, propelling the market forward. As research in proteomics continues to advance, the proteomic analysis application segment is expected to witness robust growth in the coming years.

By Distribution Channel

Online Stores:

Online Stores have emerged as a significant distribution channel for life science tools and reagents, providing researchers with convenient access to a wide variety of products. The growth of e-commerce in the life sciences sector has been accelerated by the increasing reliance on digital solutions and the need for streamlined purchasing processes. Online platforms enable users to easily compare products, read reviews, and leverage customer support services, enhancing the overall purchasing experience. As the trend towards online purchasing continues, the online store distribution channel is expected to grow steadily, attracting a broader customer base.

Biotech Companies:

Biotech Companies serve as an essential distribution channel for life science tools and reagents, as they often develop proprietary reagents and kits tailored to specific research needs. These companies play a crucial role in bringing innovative solutions to the market, providing researchers with access to specialized tools that facilitate their studies. The close collaboration between biotech companies and academic institutions fosters an environment conducive to innovation and research advancement. As the demand for customized solutions in life sciences continues to rise, the contribution of biotech companies to the distribution channel will remain significant.

Research Institutes:

Research Institutes are major consumers of life science tools and reagents, as they are at the forefront of scientific discovery and innovation. These institutions often purchase reagents in bulk for collaborative research projects and experiments, driving considerable demand for high-quality products. The increasing number of research initiatives and funding in life sciences contributes to the growth of this distribution channel. Furthermore, as research institutes continue to expand their capabilities and explore new scientific frontiers, the demand for life science tools and reagents from this channel is expected to rise significantly.

Hospitals & Clinics:

Hospitals & Clinics are critical end-users of life science tools and reagents, particularly in the context of clinical diagnostics and patient care. The increasing emphasis on accurate and timely diagnostic testing has heightened the demand for high-quality reagents in these settings. As healthcare providers adopt advanced diagnostic technologies and methodologies, the need for reliable and efficient life science tools becomes paramount. The ongoing focus on improving patient outcomes further drives the demand for reagents and diagnostic solutions within hospitals and clinics, contributing to the growth of this distribution channel.

Diagnostic Centers:

Diagnostic Centers are specialized facilities that rely heavily on life science tools and reagents to conduct a wide array of tests and analyses. The rising demand for diagnostic testing, driven by the increasing prevalence of various diseases, underscores the importance of having access to high-quality reagents and tools. These centers often require a diverse range of products to support various testing methodologies, from molecular diagnostics to traditional laboratory tests. As the healthcare landscape continues to evolve and expand, the demand for life science tools and reagents from diagnostic centers is expected to grow, fueled by the need for accurate and timely testing solutions.

By Ingredient Type

PCR Reagents:

PCR Reagents are essential components in polymerase chain reaction (PCR) techniques, which are widely used in molecular biology to amplify DNA sequences. The growing applications of PCR in fields such as clinical diagnostics, genetic research, and forensics have significantly boosted the demand for PCR reagents. As new advancements in PCR technologies, including digital PCR and quantitative PCR, are developed, the market for these reagents is expected to expand further. The increasing focus on infectious disease testing and the need for rapid diagnostics are additional factors that will contribute to the growth of the PCR reagent segment.

Cell Culture Media:

Cell Culture Media are critical for maintaining and growing cells in laboratory settings, making them indispensable in life sciences research. The increasing adoption of cell-based assays and techniques in drug discovery and development underscores the importance of high-quality cell culture media. Researchers are continually seeking optimized formulations that provide the necessary nutrients and growth factors for different cell types. As the demand for cell-based therapies and regenerative medicine grows, the market for cell culture media is anticipated to see substantial growth, driven by ongoing research and technological advancements.

Antibodies:

Antibodies are pivotal components in various life science applications, including research, diagnostics, and therapeutics. Their demand has surged due to the increasing recognition of their role in targeted therapies and personalized medicine. High-quality antibodies are essential for accurate and reliable research results, making them a crucial ingredient type in the life sciences market. The development of novel antibody formats and production techniques continues to enhance their availability and specificity, further boosting their demand. As research and clinical applications involving antibodies expand, the market for this ingredient type is expected to grow significantly.

Enzymes:

Enzymes are vital reagents used in numerous biochemical applications, including molecular biology, diagnostics, and industrial processes. The growing emphasis on enzyme-based assays and diagnostics has increased the demand for enzymes in various research applications. Furthermore, advancements in enzyme engineering and production methods have led to the development of more efficient and specific enzymes, further driving market growth. As researchers continue to explore innovative applications for enzymes in drug development and biotechnology, the market for this ingredient type is projected to expand steadily.

Buffers & Diluents:

Buffers & Diluents are widely used in laboratory settings to maintain pH and stabilize biological samples during experimentation. These reagents are indispensable in a variety of applications, including protein purification, nucleic acid analysis, and immunoassays. The growing number of research initiatives and the increasing focus on reproducibility in scientific studies underscore the importance of high-quality buffers and diluents. As the demand for reliable laboratory reagents continues to rise, the market for buffers and diluents is expected to see consistent growth, driven by ongoing research and advancements in life sciences.

By Region

The North American region holds a significant share of the Life Science Tools & Reagents Market, primarily due to the presence of a well-established pharmaceutical and biotechnology industry, coupled with substantial research funding. The United States, in particular, is a global leader in life sciences research, contributing to the high demand for innovative tools and reagents. The market in North America is projected to grow at a CAGR of 7% during the forecast period, fueled by ongoing advancements in genomics and proteomics research, along with increasing investments in drug discovery initiatives. The region's robust healthcare infrastructure and emphasis on personalized medicine also enhance the demand for life science tools and reagents.

Europe is another key region in the Life Science Tools & Reagents Market, characterized by a strong focus on research and development across various countries. The market in Europe is expected to grow steadily, driven by increasing collaborations between academic institutions and industry players, as well as the rising prevalence of chronic diseases necessitating advanced diagnostic solutions. The European life sciences sector is also witnessing significant investment in biopharmaceuticals and personalized medicine, further supporting the growth of the tools and reagents market. As research initiatives expand in this region, the demand for innovative life science solutions will continue to rise, contributing to the overall market growth.

Opportunities

The Life Science Tools & Reagents Market is ripe with opportunities, particularly in the realm of personalized medicine and targeted therapies. As the focus on individualized treatment plans intensifies, there is a growing demand for reagents and tools that can facilitate personalized diagnostics and therapeutic approaches. Researchers and healthcare professionals are increasingly seeking solutions that enable them to tailor treatments based on a patient's genetic and molecular profile, paving the way for innovative product development. This trend presents significant growth potential for companies that can provide advanced life science tools and reagents that address these emerging needs in personalized healthcare.

Another opportunity lies in the expansion of emerging markets, particularly in Asia-Pacific and Latin America. The increasing investments in healthcare infrastructure, growing biotechnology sectors, and rising research and development activities in these regions are driving demand for life science tools and reagents. Additionally, the growing prevalence of chronic diseases in these regions, along with the need for improved diagnostic solutions, further enhances market opportunities. Companies that strategically target these emerging markets can position themselves for success in a rapidly evolving landscape, leveraging the growing demand for innovative life science solutions.

Threats

Despite the positive outlook for the Life Science Tools & Reagents Market, several threats could pose challenges to its growth. One significant threat is the rapid pace of technological advancements in the field, which can result in product obsolescence and increased competition. Companies must continually innovate and improve their product offerings to remain relevant in a highly competitive market. Additionally, the increasing regulatory scrutiny and stringent quality standards for life science products can pose challenges for companies, particularly smaller ones that may lack the resources to comply with these regulations. As the market becomes more competitive, the ability to navigate regulatory landscapes while maintaining product quality will be crucial for success.

Moreover, fluctuations in raw material prices and supply chain disruptions can impact the production and availability of life science tools and reagents. The reliance on global supply chains for sourcing raw materials may expose companies to risks related to geopolitical tensions and trade policies. Additionally, the ongoing impact of the COVID-19 pandemic has highlighted vulnerabilities in supply chains, leading to potential delays and increased costs. Companies must develop strategies to mitigate these risks and ensure a steady supply of high-quality products to meet customer demand.

Competitor Outlook

• Thermo Fisher Scientific
• Merck Group
• Agilent Technologies
• Bio-Rad Laboratories
• Illumina
• QIAGEN
• GE Healthcare
• PerkinElmer
• F. Hoffmann-La Roche AG
• Beckman Coulter
• Danaher Corporation
• Promega Corporation
• Takara Bio
• Sigma-Aldrich (part of Merck KGaA)
• Sysmex Corporation

The competitive landscape of the Life Science Tools & Reagents Market is characterized by a diverse array of companies ranging from established players to emerging startups. Key industry participants are investing heavily in research and development to introduce innovative products and expand their portfolios. Collaboration between academia and industry is also prevalent, as companies seek to leverage cutting-edge research to enhance their product offerings. Additionally, mergers and acquisitions are common strategies employed by companies to consolidate their positions in the market and broaden their geographical reach. Such strategic initiatives help companies to stay competitive and respond to the evolving needs of researchers and healthcare professionals.

Thermo Fisher Scientific is a leading player in the Life Science Tools & Reagents Market, well-known for its extensive range of products and services catering to various research and clinical applications. The company's commitment to innovation and customer service has allowed it to maintain a strong position in the market. With a focus on genomics, proteomics, and cell biology, Thermo Fisher continues to expand its offerings through acquisitions and partnerships with research institutions. Similarly, Merck Group, another major player, has a diverse portfolio that includes life science tools, reagents, and services aimed at supporting scientific research across multiple disciplines. Their continued investment in R&D and strategic collaborations with industry partners position them as a formidable competitor in the market.

Agilent Technologies is also a key player, specializing in analytical instruments and reagents used in life sciences research. The company has a strong emphasis on innovation, continuously developing advanced technologies to meet the evolving needs of researchers. With strategic acquisitions and a focus on expanding its product offerings in genomics, proteomics, and diagnostics, Agilent Technologies is well-positioned to capitalize on the growing demand for life science solutions. Lastly, Illumina has established itself as a market leader in genomics, particularly in next-generation sequencing and array-based solutions. The company's commitment to providing high-quality sequencing technologies and reagents has made it a preferred choice for researchers in genomics and molecular biology, reinforcing its strong presence in the life sciences market.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 QIAGEN
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Illumina
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Takara Bio
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Merck Group
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 PerkinElmer
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 GE Healthcare
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Beckman Coulter
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Sysmex Corporation
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Danaher Corporation
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Promega Corporation
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Agilent Technologies
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Bio-Rad Laboratories
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 F. Hoffmann-La Roche AG
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Thermo Fisher Scientific
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Sigma-Aldrich (part of Merck KGaA)
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Life Science Tools amp Reagents Market, By Application
    • 6.1.1 Drug Discovery
    • 6.1.2 Research
    • 6.1.3 Clinical Diagnostics
    • 6.1.4 Genomic Analysis
    • 6.1.5 Proteomic Analysis
  • 6.2 Life Science Tools amp Reagents Market, By Product Type
    • 6.2.1 Cell Biology Reagents
    • 6.2.2 Genomics Tools
    • 6.2.3 Proteomics Tools
    • 6.2.4 Antibodies
    • 6.2.5 Flow Cytometry Instruments
  • 6.3 Life Science Tools amp Reagents Market, By Distribution Channel
    • 6.3.1 Online Stores
    • 6.3.2 Biotech Companies
    • 6.3.3 Research Institutes
    • 6.3.4 Hospitals & Clinics
    • 6.3.5 Diagnostic Centers

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Life Science Tools amp Reagents Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Life Science Tools amp Reagents market is categorized based on

By Product Type

• Cell Biology Reagents
• Genomics Tools
• Proteomics Tools
• Antibodies
• Flow Cytometry Instruments

By Application

• Drug Discovery
• Research
• Clinical Diagnostics
• Genomic Analysis
• Proteomic Analysis

By Distribution Channel

• Online Stores
• Biotech Companies
• Research Institutes
• Hospitals & Clinics
• Diagnostic Centers

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Thermo Fisher Scientific
• Merck Group
• Agilent Technologies
• Bio-Rad Laboratories
• Illumina
• QIAGEN
• GE Healthcare
• PerkinElmer
• F. Hoffmann-La Roche AG
• Beckman Coulter
• Danaher Corporation
• Promega Corporation
• Takara Bio
• Sigma-Aldrich (part of Merck KGaA)
• Sysmex Corporation